CD19 Antigens – Talk Bio

Actionable Insights Powered by AI

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

4 weeks ago talkbio0Tagged ACR gene, Antengene, ATG-201, CD19 Antigens, CD3 Antigens, preclinical data, TCE

Antengene; ATG-201; CD19 x CD3 TCE; ACR 2025; Preclinical Data

J&J CAR-T Therapy Achieves 100% Response Rate in Early-Stage Lymphoma Trial

5 months ago talkbio0Tagged CAR-T therapy, CD19 Antigens, CD20 Antigens, Clinical Trials, dual-targeting, Early-stage, Frequency of Responses, J&J, JNJ-4496, Lymphoma, Phase 1b, relapsed/refractory large-B-cell lymphoma

J&J; CAR-T therapy; lymphoma; early-stage; clinical trial; dual-targeting; CD19; CD20; objective response rate; Phase 1b; JNJ-4496; relapsed/refractory large B-cell lymphoma